BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 157166)

  • 1. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.
    Wiman B; Lijnen HR; Collen D
    Biochim Biophys Acta; 1979 Jul; 579(1):142-54. PubMed ID: 157166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of staphylokinase with different molecular forms of plasminogen.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin.
    Wiman B; Boman L; Collen D
    Eur J Biochem; 1978 Jun; 87(1):143-6. PubMed ID: 149657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand.
    Kuusela P; Saksela O
    Eur J Biochem; 1990 Nov; 193(3):759-65. PubMed ID: 1701146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
    Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
    Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA; Mangel WF
    Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
    Christensen U; Bangert K; Thorsen S
    FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen.
    Nilsson T; Sjöholm I; Wiman B
    Biochim Biophys Acta; 1982 Jul; 705(2):264-70. PubMed ID: 6214280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody directed against the high-affinity lysine-binding site (LBS) of human plasminogen. Role of LBS in the regulation of fibrinolysis.
    Holvoet P; Lijnen HR; Collen D
    Eur J Biochem; 1986 May; 157(1):65-9. PubMed ID: 2940088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
    Lijnen HR; Van Hoef B; Matsuo O; Collen D
    Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo.
    Holvoet P; Lijnen HR; Collen D
    J Biol Chem; 1985 Oct; 260(22):12106-11. PubMed ID: 2413020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.
    Wang H; Yu A; Wiman B; Pap S
    Eur J Biochem; 2003 May; 270(9):2023-9. PubMed ID: 12709062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lysine- and arginyl-binding sites of plasminogen domains].
    Kudinov SA
    Ukr Biokhim Zh (1978); 1985; 57(5):23-35. PubMed ID: 2932824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe.
    Miles LA; Plow EF
    Biochemistry; 1986 Nov; 25(22):6926-33. PubMed ID: 3099830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.
    Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D
    Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.